SGLT2 Inhibitors, but Not GLP-1 Receptor Agonists, Reduce Incidence of Gout in People Living With Type 2 Diabetes Across the Therapeutic Spectrum
Titel:
SGLT2 Inhibitors, but Not GLP-1 Receptor Agonists, Reduce Incidence of Gout in People Living With Type 2 Diabetes Across the Therapeutic Spectrum
Auteur:
Preston, Frank G. Anson, Matthew Riley, David R. Ibarburu, Gema H. Henney, Alexander Lip, Gregory Y.H. Cuthbertson, Daniel J. Alam, Uazman Zhao, Sizheng S.